These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 27615810)

  • 1. Visualization and ligand-induced modulation of dopamine receptor dimerization at the single molecule level.
    Tabor A; Weisenburger S; Banerjee A; Purkayastha N; Kaindl JM; Hübner H; Wei L; Grömer TW; Kornhuber J; Tschammer N; Birdsall NJ; Mashanov GI; Sandoghdar V; Gmeiner P
    Sci Rep; 2016 Sep; 6():33233. PubMed ID: 27615810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine D2 Receptors Dimers: How can we Pharmacologically Target Them?
    Carli M; Kolachalam S; Aringhieri S; Rossi M; Giovannini L; Maggio R; Scarselli M
    Curr Neuropharmacol; 2018 Jan; 16(2):222-230. PubMed ID: 28521704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pH dependence of ligand binding to D2 dopamine receptors.
    D'Souza UM; Strange PG
    Biochemistry; 1995 Oct; 34(41):13635-41. PubMed ID: 7577953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine D2 receptor dimer formation: evidence from ligand binding.
    Armstrong D; Strange PG
    J Biol Chem; 2001 Jun; 276(25):22621-9. PubMed ID: 11278324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical reevaluation of spiperone and benzamide binding to dopamine D2 receptors: evidence for identical binding sites.
    Malmberg A; Jerning E; Mohell N
    Eur J Pharmacol; 1996 May; 303(1-2):123-8. PubMed ID: 8804920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Class-A GPCR Dopamine D2 Receptor Forms Transient Dimers Stabilized by Agonists: Detection by Single-Molecule Tracking.
    Kasai RS; Ito SV; Awane RM; Fujiwara TK; Kusumi A
    Cell Biochem Biophys; 2018 Jun; 76(1-2):29-37. PubMed ID: 29116599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonist-radioligand binding to D2L-receptors in intact cells.
    Packeu A; De Backer JP; Van Liefde I; Vanderheyden PM; Vauquelin G
    Biochem Pharmacol; 2008 Jun; 75(11):2192-203. PubMed ID: 18436192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of [3H]nemonapride and [3H]spiperone binding to D2(long) dopamine receptors.
    Vile JM; Strange PG
    Biochem Soc Trans; 1995 Feb; 23(1):90S. PubMed ID: 7538954
    [No Abstract]   [Full Text] [Related]  

  • 9. [3H]nemonapride and [3H]spiperone label equivalent numbers of D2 and D3 dopamine receptors in a range of tissues and under different conditions.
    Vile JM; D'Souza UM; Strange PG
    J Neurochem; 1995 Feb; 64(2):940-3. PubMed ID: 7830089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A consideration of the dopamine D2 receptor monomer-dimer equilibrium and the anomalous binding properties of the dopamine D2 receptor ligand, N-methyl spiperone.
    Logan J; Fowler JS; Dewey SL; Volkow ND; Gatley SJ
    J Neural Transm (Vienna); 2001; 108(3):279-86. PubMed ID: 11341479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homobivalent Dopamine D
    Ullmann T; Gienger M; Budzinski J; Hellmann J; Hübner H; Gmeiner P; Weikert D
    ACS Chem Biol; 2021 Feb; 16(2):371-379. PubMed ID: 33435665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zinc allosterically modulates antagonist binding to cloned D1 and D2 dopamine receptors.
    Schetz JA; Sibley DR
    J Neurochem; 1997 May; 68(5):1990-7. PubMed ID: 9109525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of in vitro binding properties of a series of dopamine antagonists and agonists for cloned human dopamine D2S and D2L receptors and for D2 receptors in rat striatal and mesolimbic tissues, using [125I] 2'-iodospiperone.
    Leysen JE; Gommeren W; Mertens J; Luyten WH; Pauwels PJ; Ewert M; Seeburg P
    Psychopharmacology (Berl); 1993; 110(1-2):27-36. PubMed ID: 7870895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct Dopamine D₂ Receptor Antagonists Differentially Impact D₂ Receptor Oligomerization.
    Wouters E; Marín AR; Dalton JAR; Giraldo J; Stove C
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric D1/D2 dopamine receptors. Distinct determinants of selective efficacy, potency, and signal transduction.
    Kozell LB; Machida CA; Neve RL; Neve KA
    J Biol Chem; 1994 Dec; 269(48):30299-306. PubMed ID: 7982941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of a True Bivalent Ligand with Picomolar Binding Affinity for a G Protein-Coupled Receptor Homodimer.
    Pulido D; Casadó-Anguera V; Pérez-Benito L; Moreno E; Cordomí A; López L; Cortés A; Ferré S; Pardo L; Casadó V; Royo M
    J Med Chem; 2018 Oct; 61(20):9335-9346. PubMed ID: 30257092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
    Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ
    J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human dopamine D2(Longer) receptor has a high-affinity state and inhibits adenylyl cyclase.
    Liu IS; George SR; Seeman P
    Brain Res Mol Brain Res; 2000 May; 77(2):281-4. PubMed ID: 10837924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular distribution of dopamine D1 and D2 receptors in rat medial prefrontal cortex.
    Vincent SL; Khan Y; Benes FM
    J Neurosci; 1993 Jun; 13(6):2551-64. PubMed ID: 8501521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of dopamine transport and binding of [3H] spiperone to dopamine D2 receptor by acute Pb-toxicity in vivo.
    Sulkowski G; Dabrowska-Bouta B; Waśkiewicz J; Rafałowska U
    Folia Neuropathol; 1999; 37(4):205-9. PubMed ID: 10705638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.